TRPV1 and atherosclerosis: constructed a switch for photothermal activation of the TRPV1 signaling pathway by combining copper sulfide (CuS) nanoparticles with TRPV1 monoclonal antibodies (CuS-TRPV1 NPs) to alleviate atherosclerosis through nanoparticle-mediated photothermal modulation of TRPV1 [35].